Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
0%
OVERLAP
BY WEIGHT
0
# OF OVERLAPPING
HOLDINGS
IXJ
114
HOLDINGS
0%
ALSO IN
HOLDINGS
nan%
ALSO IN IXJ
SECTOR DRIFT (IXJ minus )
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in |
Overlap | |
|---|---|---|---|---|
IXJ Overweight Relative to
 |
ELI LILLY & CO | 8.8% |
|
JOHNSON & JOHNSON | 5.3% |
|
ABBVIE INC | 4.6% |
|
UNITEDHEALTH GROUP INC | 4.0% |
|
ABBOTT LABORATORIES | 3.4% |
 |
ROCHE HOLDING LTD | 3.3% |
|
NOVARTIS AG | 3.3% |
 |
ASTRAZENECA PLC | 3.1% |
 |
NOVO NORDISK A/S-B | 3.1% |
|
MERCK & CO. INC. | 2.9% |
IXJ Underweight Relative to
 |
GRIFOLS, S.A. CLASS A | 0.0% |
|
ZEALAND PHARMA A/S | 0.1% |
 |
GETINGE AB-B SHS | 0.1% |
 |
ONO PHARMACEUTICAL CO LTD | 0.1% |
|
SO-NET M3 INC | 0.1% |
|
DAVITA INC | 0.1% |
 |
SARTORIUS STEDIM BIOTECH SA | 0.1% |
 |
SARTORIUS AG PREF | 0.1% |
 |
REDE D'OR SAO LUIZ SA | 0.1% |
|
CHARLES RIVER LABORATORIES | 0.1% |